KR100825279B1 - Dnα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자 - Google Patents
Dnα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자 Download PDFInfo
- Publication number
- KR100825279B1 KR100825279B1 KR1020060119613A KR20060119613A KR100825279B1 KR 100825279 B1 KR100825279 B1 KR 100825279B1 KR 1020060119613 A KR1020060119613 A KR 1020060119613A KR 20060119613 A KR20060119613 A KR 20060119613A KR 100825279 B1 KR100825279 B1 KR 100825279B1
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- seq
- dna
- dna polymerase
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 63
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 46
- 230000000694 effects Effects 0.000 title abstract description 19
- 102000004190 Enzymes Human genes 0.000 title description 7
- 108090000790 Enzymes Proteins 0.000 title description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 43
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 43
- 230000001965 increasing effect Effects 0.000 claims abstract description 16
- 239000013598 vector Substances 0.000 claims abstract description 12
- 108020004414 DNA Proteins 0.000 claims description 27
- 238000003752 polymerase chain reaction Methods 0.000 claims description 24
- 150000007523 nucleic acids Chemical group 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000006116 polymerization reaction Methods 0.000 claims description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 230000004543 DNA replication Effects 0.000 claims description 3
- 241001495444 Thermococcus sp. Species 0.000 abstract description 14
- 241000205188 Thermococcus Species 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000012634 fragment Substances 0.000 abstract description 2
- 101100046502 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TNA1 gene Proteins 0.000 description 14
- 101100394230 Caenorhabditis elegans ham-1 gene Proteins 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- UFJPAQSLHAGEBL-RRKCRQDMSA-N dITP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 UFJPAQSLHAGEBL-RRKCRQDMSA-N 0.000 description 9
- GKUJGEJKDIGMCJ-UHFFFAOYSA-N 6-amino-3-(4-fluorophenyl)-4-[5-(4-fluorophenyl)-1h-pyrazol-4-yl]-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile Chemical compound N=1NC(C=2C=CC(F)=CC=2)=C2C=1OC(N)=C(C#N)C2C=1C=NNC=1C1=CC=C(F)C=C1 GKUJGEJKDIGMCJ-UHFFFAOYSA-N 0.000 description 8
- 101100045395 Mus musculus Tap1 gene Proteins 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 102000002087 Ham1-like proteins Human genes 0.000 description 4
- 108050009407 Ham1-like proteins Proteins 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- -1 Aliphatic amino acids Chemical class 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000007205 yps medium Substances 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 2
- HAEJPQIATWHALX-KQYNXXCUSA-N ITP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 HAEJPQIATWHALX-KQYNXXCUSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101710103779 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 239000006391 Luria-Bertani Medium Substances 0.000 description 1
- 241001003007 Methanocaldococcus jannaschii DSM 2661 Species 0.000 description 1
- 102000057361 Pseudogenes Human genes 0.000 description 1
- 108091008109 Pseudogenes Proteins 0.000 description 1
- 241001467519 Pyrococcus sp. Species 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000981880 Thermococcus kodakarensis KOD1 Species 0.000 description 1
- 241000482676 Thermococcus thioreducens Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000037048 polymerization activity Effects 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060119613A KR100825279B1 (ko) | 2006-11-30 | 2006-11-30 | Dnα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자 |
| PCT/KR2007/006150 WO2008066350A1 (fr) | 2006-11-30 | 2007-11-30 | Ditpase et gènes le codant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060119613A KR100825279B1 (ko) | 2006-11-30 | 2006-11-30 | Dnα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR100825279B1 true KR100825279B1 (ko) | 2008-04-25 |
Family
ID=39468084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020060119613A Active KR100825279B1 (ko) | 2006-11-30 | 2006-11-30 | Dnα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR100825279B1 (fr) |
| WO (1) | WO2008066350A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101142950B1 (ko) | 2008-12-05 | 2012-05-08 | 성균관대학교산학협력단 | 써모코커스 마리너스 균주 유래의 내열성 dna 중합효소 및 이의 이용 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970010965A (ko) * | 1995-08-25 | 1997-03-27 | 클라우스너 프리돌린, 보러 롤란드 | 핵산 증폭 방법 |
| KR20070039418A (ko) * | 2005-10-08 | 2007-04-12 | 한국해양연구원 | 고호열성 dna 중합효소 및 이의 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3112148B2 (ja) * | 1995-05-31 | 2000-11-27 | 東洋紡績株式会社 | 核酸の増幅方法およびその試薬 |
| EP1456394B2 (fr) * | 2001-11-28 | 2011-04-27 | Bio-Rad Laboratories, Inc. | Procedes d'utilisation de polymerases ameliorees |
-
2006
- 2006-11-30 KR KR1020060119613A patent/KR100825279B1/ko active Active
-
2007
- 2007-11-30 WO PCT/KR2007/006150 patent/WO2008066350A1/fr active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970010965A (ko) * | 1995-08-25 | 1997-03-27 | 클라우스너 프리돌린, 보러 롤란드 | 핵산 증폭 방법 |
| KR20070039418A (ko) * | 2005-10-08 | 2007-04-12 | 한국해양연구원 | 고호열성 dna 중합효소 및 이의 제조방법 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101142950B1 (ko) | 2008-12-05 | 2012-05-08 | 성균관대학교산학협력단 | 써모코커스 마리너스 균주 유래의 내열성 dna 중합효소 및 이의 이용 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008066350A1 (fr) | 2008-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101721396B1 (ko) | 향상된 전환 활성을 가지는 l-아라비노스 이성화효소 변이체 및 이를 이용한 d-타가토스의 생산 방법 | |
| KR100844358B1 (ko) | 돌연변이 dna 중합효소들 및 그의 유전자들 | |
| KR100825279B1 (ko) | Dnα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자 | |
| WO2007043769A1 (fr) | Adn polymerase hyperthermophile et son procede de preparation | |
| KR100777230B1 (ko) | 써모코커스 유래 돌연변이 dna 중합효소들 및 그의유전자들 | |
| CN117821412B (zh) | 一种dCE-KOD DNA聚合酶及其制备方法和应用 | |
| CN109735516B (zh) | 受核苷酸片段引导具有特异核酸内切酶活性的piwi蛋白 | |
| CN112029744A (zh) | Dna聚合酶及其编码基因、制备方法和pcr应用 | |
| WO2007117331A2 (fr) | Nouvelle adn polymerase provenant d'un thermoanaerobacter tengcongenesis | |
| JP4714848B2 (ja) | Dnaポリメラーゼ変異体 | |
| KR100777228B1 (ko) | 고호열성 디유티피아제 및 이의 제조방법 | |
| KR101416097B1 (ko) | 롱 pcr이 가능한 dna 중합효소 및 이의 유전자들 | |
| RU2333956C1 (ru) | ШТАММ E.coli BL21(DE3)/pET-hHSP70 - ПРОДУЦЕНТ БЕЛКА ТЕПЛОВОГО ШОКА ЧЕЛОВЕКА HSP70 | |
| JPWO2002010360A1 (ja) | 新規dna合成酵素 | |
| KR100969477B1 (ko) | 써모코커스 구아이마센시스 균주 유래 내열성 dna중합효소 및 이를 이용한 중합효소 연쇄반응 방법 | |
| WO1995013366A1 (fr) | Gene d'ectoine synthetase | |
| KR20110040116A (ko) | 돌연변이 나노아케움 이퀴탄스 a523r dna 중합효소 및 이의 이용 | |
| KR20110126011A (ko) | Dna 중합효소 t7 및 이의 유전자들 | |
| KR100562688B1 (ko) | 에어로파이룸 퍼닉스에서 분리된 변이 디엔에이 중합효소 및 그의 제조방법 | |
| CN114761548A (zh) | 海洋dna聚合酶i | |
| EP4041877A1 (fr) | Adn polymérase et exonucléase 3' à 5' dérivée de l'adn polymérase | |
| CN119823972A (zh) | 腈水解酶及其在对氰基苯甲酸制备中的应用 | |
| KR20110126012A (ko) | Dna 중합효소 f7 및 이의 유전자들 | |
| KR20110126009A (ko) | Dna 중합효소 p7 및 이의 유전자들 | |
| JP2001299348A (ja) | Dnaポリメラーゼ活性と3’−5’エキソヌクレアーゼ活性を有する耐熱性ヘテロダイマー酵素およびその製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20061130 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070928 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20080324 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080421 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20080421 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20110421 Start annual number: 4 End annual number: 4 |
|
| FPAY | Annual fee payment | ||
| PR1001 | Payment of annual fee |
Payment date: 20120402 Start annual number: 5 End annual number: 5 |
|
| FPAY | Annual fee payment | ||
| PR1001 | Payment of annual fee |
Payment date: 20130423 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20140328 Start annual number: 7 End annual number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20150421 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20150421 Start annual number: 8 End annual number: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20160411 Year of fee payment: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160411 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20170410 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170410 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20180411 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20190415 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20190415 Start annual number: 12 End annual number: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20200413 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20210322 Start annual number: 14 End annual number: 14 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220329 Start annual number: 15 End annual number: 15 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230321 Start annual number: 16 End annual number: 16 |